EUVIMEDEUVIMED entdecken
Vergleichsstudie

Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis

Kaiya Hassan iD, Robert Kinan, Ashley Casey, Miranda Dermady, Britta Mizuki, Katerina Stanilova, Heather Savage, Helen Yuan, Emma Hillis, Connor Bertaut, Taylor Guillory, Eric Coons iD

European Journal of Haematology · 2025-03 · 114 (3) · 429-435

DOI: 10.1111/ejh.14350 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Haematology, online erschienen am 14.11.2024. Verfasst von Kaiya Hassan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ochsner Medical Center, New Orleans, USA. Hauptthemen laut MEDLINE: Thrombocytopenia, Heparin, Anticoagulants, Warfarin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

No existing studies compare oral anticoagulants to treat heparin‐induced thrombocytopenia with or without thrombosis (HIT/HITT). This retrospective study evaluated thrombotic and bleeding outcomes in adults treated for HIT/HITT with a direct oral anticoagulant (DOAC) or warfarin between 2012 and 2023 within the Ochsner Health System. Patients with mechanical heart valves, valvular atrial fibrillation, antiphospholipid syndrome, active malignancy, or venous thromboembolism (VTE) within the previous 6 months were excluded. The primary outcome was a composite of new or progressive VTE or arterial thromboembolism. Secondary outcomes included major and clinically relevant non‐major bleeding, duration of hospitalization, time to platelet recovery, and incidence of skin necrosis, gangrene, and amputation. Forty‐nine patients receiving a DOAC and 30 patients receiving warfarin were included. Baseline characteristics were similar between cohorts. There were non‐statistically significant increased rates of both the primary outcome (8.9% vs. 4.3%, p = 0.65) and the composite bleeding outcome (32.7% vs. 23.3%, p = 0.37) in the DOAC cohort. Larger, prospective studies are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaHeparinAnticoagulantsWarfarinThrombosisHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAdministration, OralHemorrhageTreatment OutcomeAdultAged, 80 and overFactor Xa Inhibitors

Stichwörter der Autor:innen

anticoagulation therapyheparin‐induced thrombocytopeniaoral anticoagulants

Substanzen

HeparinAnticoagulantsWarfarinFactor Xa Inhibitors

Autor:innen und Institutionen

  • Ochsner Medical Center, New Orleans, USA.
  • Xavier University, New Orleans, USA.

ORCID-Profile: Kaiya Hassan, Eric Coons

Zitieren

APA

Hassan, K., Kinan, R., Casey, A., Dermady, M., Mizuki, B., Stanilova, K., Savage, H., Yuan, H., Hillis, E., Bertaut, C., Guillory, T., & Coons, E. (2025). Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis. European Journal of Haematology, 114(3), 429-435. https://doi.org/10.1111/ejh.14350

Vancouver

Hassan K, Kinan R, Casey A, Dermady M, Mizuki B, Stanilova K, et al. Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis. European Journal of Haematology. 2025;114(3):429-435. doi:10.1111/ejh.14350

BibTeX
@article{Hassan2025,
  author = {Hassan, Kaiya and Kinan, Robert and Casey, Ashley and Dermady, Miranda and Mizuki, Britta and Stanilova, Katerina and Savage, Heather and Yuan, Helen and Hillis, Emma and Bertaut, Connor and Guillory, Taylor and Coons, Eric},
  title = {Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis},
  journal = {European Journal of Haematology},
  year = {2025},
  volume = {114},
  number = {3},
  pages = {429--435},
  doi = {10.1111/ejh.14350}
}
Kostenlos starten →